🇺🇸 FDA
Patent

US 10512630

Compositions and methods for treating cancer

granted A61KA61K31/33A61K31/343

Quick answer

US patent 10512630 (Compositions and methods for treating cancer) held by The Regents of the University of California expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/33, A61K31/343, A61K31/365, A61K45/06